Episode 342: May 2022 Retinal Physician Discussion - Patient and Physician Perceptions of Intravitreal Injection Therapy, RVO Clinical Trials, Laser for Diabetic Retinopathy, and Uveitis Pearls

Drs. Greg Lee, Kat Talcott, and Akshay Thomas join to discuss the May 2022 edition of Retinal Physician, found online at http://www.retinalphysician.com. Topics covered include patient and physician Perceptions of intravitreal injection therapy, retinal vein occlusion Clinical Trials, laser for diabetic retinopathy, and uveitis pearls. Relevant Financial Disclosures: Dr. Sridhar is a consultant for Genentech and Regeneron. Dr. Talcott is a consultant for Genentech, Regenxbio, and Zeiss. Dr. Thomas is a consultant for Allergan, Avesis, Bausch and Lomb, and Novartis. Dr. Lee is a consultant for Allergan, Alimera, Apellis, and Eyepoint.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Om Podcasten

An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists